Investors & VC Firms in Belgium
101 firms in this list, with a median first check of $587.5K. 6 of them lead rounds. Generated from verified public data and updated continuously.
BlackFin Capital Partners
BrusselsSeries A–Growth
Butler Industries
Paris$10.8M – $54M
3 people
Creafund Asset Management nv
Sint-Martens-LatemGrowth$5.4M – $27M
3 people
Fund+
LeuvenSeries A–Series B$5.4M – $16.2M
3 people
Nausicaa Ventures
MechelenSeries C–Late Stage$1.1M – $4.3M
3 people
RTW Investments L.P.
New YorkSeed–Series A
6 people
Seido Capital
BrusselsPre-Seed–Series B$270K – $2.7M
3 people
Vento
TorinoPre-Seed–Seed$162K – $1.1M
3 people
BioGeneration Ventures
NaardenSeed–Late Stage
5 people
Newton Biocapital
BrusselsSeed–Series A
5 people
Novalis LifeSciences
HamptonSeed–Late Stage
5 people
UCB Ventures
BrusselsSeed–Series A
5 people
Vesalius Biocapital III Partners SàRL
StrassenSeries C–Late Stage$10.8M
5 people
Agri Investment Fund
LeuvenSeries A–Late Stage$540K
2 people
Ark Angels Activator Fund
HasseltSeed–Series B$270K – $1.1M
2 people
Innovation Fund sa/nv
SchaerbeekSeed–Series B$270K – $2.7M
2 people
Satgana
LuxembourgSeed–Series A$108K – $324K
2 people
Volve Capital
AmsterdamPre-Seed–Seed$216K – $540K
2 people
White Fund
LiègeSeries A–Series B$2.2M – $5.4M
2 people
AXE Investments N.V.
AntwerpSeed–Series B$1.1M – $6.5M
1 person
Épimède
LiègeSeries A–Series B$1.1M – $7.6M
1 person
fronttrail Equity Partners GmbH
WollerauGrowth$5.4M – $21.6M
1 person
Helsana HealthInvest AG
DübendorfSeries A–Series B
4 people
LeadBlock Partners
LondonSeries B–Late Stage
4 people
Related lists
Seed Investors & VC Firms (7051)Series A Investors & VC Firms (4959)Crypto & Web3 Investors & VC Firms (3510)Investors & VC Firms in United States (2654)Series B Investors & VC Firms (2615)Pre-Seed Investors & VC Firms (2349)Late Stage Investors & VC Firms (2244)Seed Investors & VC Firms in United States (2211)Series A Investors & VC Firms in United States (2107)SaaS Investors & VC Firms (1994)
Data sourced from public filings and firms' own websites — see our methodology.